专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2006021335A3 PEPTIDE MIXTURE FROM PEPTIDES HAVING A MOLECULAR WEIGHT OF FROM 1000 TO 5000 DALTON 审中-公开
标题翻译：肽的分子量从1000-5000 DALTON肽混合物
公开(公告)号：WO2006021335A3
公开(公告)日：2006-04-20
申请号：PCT/EP2005008805
申请日：2005-08-12
申请人： NUTRICIA NV , BOEHM GUENTHER , BEERMANN CHRISTOPHER , GEORGI GILDA , STAHL BERND , SCHMITT JOACHIM , BOCK NADINE , KELM SOERGE
发明人： BOEHM GUENTHER , BEERMANN CHRISTOPHER , GEORGI GILDA , STAHL BERND , SCHMITT JOACHIM , BOCK NADINE , KELM SOERGE
IPC分类号： A61K38/02 , A23L1/305 , A61K35/20 , A61K36/18 , A61P35/00 , A61P37/00
CPC分类号： A23J3/346 , A23J3/344 , A23L33/18 , A23L33/40 , A61K35/20 , A61K36/06 , A61K36/31 , A61K36/48 , A61K36/88 , A61K38/168 , A61K38/1709 , A61K2300/00
摘要： The invention relates to the use of a peptide mixture from peptides having a molecular weight of from 1000 to 5000 Dalton for use in the prevention and/or treatment of cancers, of diseases associated with the developmental disturbance of the immune system, diseases of the immune system, autoimmune responses, allergies and inflammations in humans. The invention also relates to a protein component containing said peptide mixture and to formula foodstuff containing said peptide mixture. The peptides are preferably obtained from non-human proteins that are suitable for consumption, especially by enzymatic or hydrolytic cleavage of the proteins.
摘要翻译：本发明涉及使用具有从1000到5000道尔顿的肿瘤疾病的预防和/或治疗时，与免疫系统的发育障碍相关的免疫系统的疾病，自身免疫反应，变态反应和，疾病的分子量的肽的肽混合物的炎症在人类中，含有这样的肽混合物中的蛋白质组分，并且这种肽混合物含有配方食品。所述肽优选从食用合适的非人类蛋白由这些蛋白质的酶或水解裂解获得的，特别是。

2. 发明申请

WO0142263A3 OLIGOSACCHARIDE MIXTURE 审中-公开
标题翻译：寡糖
公开(公告)号：WO0142263A3
公开(公告)日：2001-11-01
申请号：PCT/EP0012345
申请日：2000-12-07
申请人： NUTRICIA NV , STAHL BERND , BOEHM GUENTHER , FINKE BERNDT , GEORGI GILDA , JELINEK JUERGEN , SCHMITT JOACHIM J
发明人： STAHL BERND , BOEHM GUENTHER , FINKE BERNDT , GEORGI GILDA , JELINEK JUERGEN , SCHMITT JOACHIM J
IPC分类号： A23L29/30 , A23L33/10 , A61K31/702 , A61K35/20 , A61K45/06 , A61P1/00 , A61P1/14 , C07H3/06 , A23L1/09 , A61K31/70
CPC分类号： A61K45/06 , A23L29/30 , A23L33/10 , A23V2002/00 , A61K31/702 , A61K35/20 , A61K2300/00 , A23V2250/28
摘要： The invention relates to an oligosaccharide mixture based on oligosaccharides produced from one or several animal milks and which are composed of two or more monosaccharide units. Said oligosaccharide mixture is characterized in that it comprises at least two oligosaccharide fractions which are each composed of at least two different oligosaccharides. The invention is further cahracterized in that lactose does not pertain thereto and the total spectrum of the oligosaccharides present in the oligosaccharide mixture differs from those present in animal milk or animal milks, wherefrom the oligosaccharide fractions are extracted and that a) if said oligosaccharides are extracted from only one animal milk, the proportion of neutral oligosaccharides to acidic oligosaccharides is 90 -60: 10 - 40 weight %, or b) if said oligosaccharides are extracted from at least two animal milks, the oligosaccharides extracted from two different animal milks each make up 10 weight % of the total amount of oligosaccharides present in the oligosaccharide mixture. The oligosaccharide mixture according to the invention approximates to human milk with respect to its positive properties and in particular its anti-infective activity.
摘要翻译：提供了一种基于由一种或多种动物乳获得并由两种或更多种单糖单元组成的低聚糖的寡糖混合物。此寡糖混合物的特征在于，它包括至少两个寡糖级分的每一个在至少两个不同的寡糖组成，其中游离的乳糖不与其相关的，即，存在于所述寡糖混合物的寡糖与从动物乳或动物乳的总频谱到或从其中获得的寡糖级分，而不同，并且如果所述寡糖只有一个是从中性寡糖的酸性寡糖90-60的比率获得动物牛奶）：10 - 40重量％，或b），其中从至少两个动物乳获得的寡糖，从每两个不同的动物乳中提取的寡糖占至少10重量存在于所述寡糖混合物的寡糖总量的％。该erfingungsgemässe寡糖在他们的积极作用方面，特别是人乳，其抗感染作用近似。

3. 发明申请

WO2008043424A3 COMPOSITION TO TREAT OR PREVENT GASTROINTESTINAL INFECTION 审中-公开
标题翻译：组合物治疗或预防胃肠道感染
公开(公告)号：WO2008043424A3
公开(公告)日：2008-06-19
申请号：PCT/EP2007008179
申请日：2007-09-20
申请人： NUTRICIA NV , BOEHM GUNTHER , SCHMITT JOACHIM , GEORGI GILDA , EULER MARCO
发明人： BOEHM GUNTHER , SCHMITT JOACHIM , GEORGI GILDA , EULER MARCO
IPC分类号： A61K38/00 , A61K38/01 , A61P1/04 , A61P31/04
CPC分类号： A23L1/3056 , A23L33/18 , A23L33/185 , A23L33/19 , A61K35/20 , A61K36/48 , A61K2300/00
摘要： The invention relates to a composition for the treatment and/or prevention of infection by gastrointestinal pathogens, in particular Helicobacter pylori and/or a disease associated with infection by said gastrointestinal pathogen in mammals. The composition comprises a pea protein hydrolysate, intact pea protein and/or camel milk protein hydrolysate.
摘要翻译：本发明涉及用于治疗和/或预防胃肠道病原体感染的组合物，特别是幽门螺杆菌和/或与哺乳动物中所述胃肠道病原体感染相关的疾病。该组合物包含豌豆蛋白水解物，完整的豌豆蛋白和/或骆驼乳蛋白水解物。

4. 发明申请

WO9712527A3 USE OF THREONINE FOR THE TREATMENT OF PHENYLKETONURIA 审中-公开
标题翻译：用于治疗苯丙酮的THREONINE的使用
公开(公告)号：WO9712527A3
公开(公告)日：1997-05-01
申请号：PCT/EP9604093
申请日：1996-09-18
申请人： MILUPA GMBH & CO KG , GEORGI GILDA , SAWATZKI GUENTHER
发明人： GEORGI GILDA , SAWATZKI GUENTHER
IPC分类号： A23L1/305 , A61K31/00 , A61K31/195 , A61K31/198 , A61K38/00 , A61K38/17 , A61P3/00
CPC分类号： A61K38/1709 , A61K31/198
摘要： The invention relates to the use of threonine for the treatment of phenylketonuria. The invention is based on the surprising discovery that the concentration of phenylalanine in the plasma of PKU patients can be reduced by additional doses of threonine. The object of the invention is therefore an composition for dietetic or pharmaceutical use in phenylketonuria, which composition contains at least 8 g threonine per 100 g amino acids. This composition may consist of foods, in particular formula foods and PKU dietetic products.
摘要翻译：本发明涉及使用苏氨酸治疗苯丙酮尿症。本发明基于惊人的发现，即可以通过额外剂量的苏氨酸来减少PKU患者血浆中苯丙氨酸的浓度。因此，本发明的目的是用于苯丙酮尿症饮食或药物用途的组合物，该组合物每100g氨基酸含有至少8克苏氨酸。该组合物可以由食物，特别是配方食品和PKU饮食产品组成。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式